Viewing Study NCT04071457


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2026-01-05 @ 9:29 AM
Study NCT ID: NCT04071457
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-15
First Post: 2019-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Sponsor: SWOG Cancer Research Network
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module